EXPERIENCE WITH THE USE OF MELDONIUM IN LONG IMMOBILIZED PATIENTS WITH CEREBROVASCULAR DISEASES


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

One of the problems in the work of general practitioners and primary care physicians is the issue of rational management of bedridden elderly patients with comorbid pathology. The main cause of prolonged immobilization of elderly patients are cerebrovascular diseases (CVD). Management of these patients should include a comprehensive therapy, influencing on the few causes of the pathogenesis of underlying disease. The research of influence of meldonium in the complex therapy on blood pressure (BP) and lipid profile as the main risk factors for CVD was conducted. It is shown that the use of meldonium in the complex therapy of long-immobilized patients with CVD enhances the hypotensive and hypolipidemic effects, accelerates the achievement of the target values of blood pressure, as well as contributes to more efficient and rapid reduction in total cholesterol levels mainly due to triglycerides and low-density lipoprotein.

Texto integral

Acesso é fechado

Sobre autores

Viktoryia Shevtsova

A.I. Evdokimov Moscow State University of Medicine and Dentistry

Email: viktoriya.sams@mail.ru
postgraduate student, Department of Therapy, Clinical Pharmacology and Emergency Medical Care 127473 Moscow, 20/1, Delegatskaya st

Arkady Vertkin

A.I. Evdokimov Moscow State University of Medicine and Dentistry

Email: kafedrakf@mail.ru
MD, Professor; Head of Department of Therapy, Clinical Pharmacology and Emergency Medical Care 127473 Moscow, 20/1, Delegatskaya st

Bibliografia

  1. Щукин Ю.В., Рябов А.Е. Хроническая ишемическая болезнь сердца в пожилом и старческом возрасте. Пособие для врачей. Самара: Волга-Бизнес, 2008. 44 с.
  2. Косарев В.В. Бабанов С.А., Астахова А.В. Фармакология и лекарственная терапия. Под ред. В.К. Лепахина. М.: Эксмо, 2009. 480 с.
  3. Dambrova M., Daija D., Liepin'sh E., Kir'ianova O., Kalvin'sh I. Biochemical mechanisms of mildronate action during ischemic stress. Lik. Sprava. 2004;2:68-74.
  4. Dambrova M., Liepinsh E., Kalvinsh I. Mildronate: cardioprotective action through carnitine-lowering. Trends Cardiovasc Med. 2002; 12:275-9.
  5. Rafalski V.A., Brunet A. Energy metabolism in adult neural stem cell fate. Prog. Neurobiol. 2011 ;93:182-203.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Bionika Media, 2015